Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOvoca Bio Regulatory News (OVB)

  • There is currently no data for OVB

Result of EGM

15 Jan 2010 11:53

RNS Number : 6340F
Ovoca Gold PLC
15 January 2010
 

OVOCA GOLD plc 

Proposed Acquisition of Magsel, Bulun and Olymp 

Capital Reorganisation

Result of Extraordinary General Meeting 

Ovoca Gold plc ("Ovoca" or the "Company") announced on 21 December 2009 that it had agreed to acquire a 100 per cent. interest in a portfolio of gold exploration projects in the Magadan region of the Russian Federation for initial consideration of approximately US$7 million and deferred consideration of up to a maximum of US$18 million. Ovoca will also assume approximately US$7.5 million of debt of the Target Companies. In addition, Ovoca announced a Capital Reorganisation consolidating every 5 Ordinary Shares into 1 New Ordinary Share creating a more appropriate capital structure and share price for the Company.

 

At an extraordinary general meeting held this morning all resolutions in relation to the Proposed Acquisition and the Capital Reorganisation were duly passed. 

Trading in the New Ordinary Shares will commence on 18 January 2010. Share certificates for Ordinary Shares will no longer be valid and new share certificates will be issued. In the case of Shareholders who hold shares through the CREST system, the New Ordinary Shares will be credited to CREST accounts on 18 January 2010. Pending the receipt of new certificates, Shareholders are still be able to trade in New Ordinary Shares and transfers of New Ordinary Shares held in certificated form would be certified against the register of members of the Company.

So as to facilitate the Capital Reorganisation, 4 Ordinary Shares were admitted to trading on the AIM and IEX at par today to increase the number of existing shares to 442,294,030 in order to ensure that the number of Ordinary Shares in issue would be exactly divisible by 5. 

Timothy McCutcheon, CEO of Ovoca said: 

"I am pleased at the support shareholders have given for this transaction and share reorganisation. With today's EGM result, Ovoca is now ready to move forward and become a leading gold exploration and mine development company in Russia. I look forward to communicating to shareholders our progress in developing our assets in Magadan."

For further information please contact:

Ovoca Gold plc

Tim McCutcheonCEO 

Tel:

7 495 916 6029 

Davy 

John Frain 

Tel:

+ 353 1 679 6363

JJ Cahill

  

In this announcement terms not otherwise defined shall have the same meaning as in the Circular to be posted to Shareholders.

This announcement contains forward-looking statements. These statements relate to the Company's future prospects, developments and business strategies. Forward-looking statements are identified by their use of terms and phrases such as 'believe', 'could', 'envisage', 'potential', 'estimate', 'expect', 'may', 'will' or the negative of those, variations or comparable expressions, including references to assumptions. The forward-looking statements in this announcement are based on current expectations and are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied by those statements. These forward-looking statements speak only as at the date of this announcement.

Davy, which is regulated in Ireland by the Financial Regulator, is acting exclusively for Ovoca and no-one else in connection with the matters described in this document. Davy will not regard any other person (whether or not a recipient of this document) as its customer or be responsible to any other person for providing the protections to customers of Davy nor for providing advice in relation to the transactions and arrangements described in this document. Davy is not making any representation or warranty, express or implied, as to the contents of this document. Davy has not approved the contents of, or any part of, this document and no liability whatsoever is accepted by Davy for the accuracy of any information or opinions contained in this document or for the omission of any information.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
REGKMGMMMKMGGZM
Date   Source Headline
5th Feb 20267:00 amRNSChange of Name
28th Jan 20268:00 amRNSReadmission - Ovoca Bio PLC
28th Jan 20267:00 amRNSFirst Day of Dealings on AIM
27th Jan 20262:32 pmRNSResult of Meeting
31st Dec 20258:00 amRNSSchedule One - Ovoca Bio Plc
31st Dec 20258:00 amRNSSchedule One - Ovoca Bio Plc
31st Dec 20257:00 amRNSNotice of AGM
31st Dec 20257:00 amRNSPublication of Admission Document
31st Dec 20257:00 amRNSPublication of Admission Document
31st Dec 20257:00 amRNSNotice of AGM
13th Nov 20257:00 amRNSChange of Broker
30th Sep 20251:09 pmRNSReplacement Half Year Report
30th Sep 20257:00 amRNSHalf-year Report
26th Jun 20257:00 amRNSPublication of 2024 Annual Report
5th Jun 20257:00 amRNSDelisting from Euronext Growth Exchange
7th May 20257:30 amRNSSuspension - Ovoca Bio plc
7th May 20257:00 amRNSProposed Acquisition, Disposal & Reverse Takeover
3rd Mar 20252:00 pmRNSManagement Changes
18th Dec 20246:00 pmRNSResult of AGM
18th Nov 20247:00 amRNSNotice of AGM
11th Oct 20245:30 pmRNSHolding(s) in Company
9th Oct 20245:45 pmRNSSale of Treasury Shares
25th Sep 20247:00 amRNSHalf-year Report
2nd Sep 20242:30 pmRNSConsultancy Agreement
15th Jul 20247:00 amRNSDirector/PDMR Shareholding
15th Jul 20247:00 amRNSDirectorate Change
28th Jun 20247:00 amRNSAnnual Financial Report
23rd Jan 20247:00 amRNSHolding(s) in Company
1st Dec 202312:00 pmRNSResult of AGM
7th Nov 20239:15 amRNSNotice of AGM
28th Sep 20237:00 amRNSInterim Results
31st Aug 20237:00 amRNSSummary Results of Phase II Study for Orenetide
30th Jun 20237:00 amRNSAnnual Financial Report
12th Jun 20237:00 amRNSUpdate on Completion Timelines for Phase II Study
16th Mar 20234:35 pmRNSPrice Monitoring Extension
16th Mar 20232:05 pmRNSSecond Price Monitoring Extn
16th Mar 20232:00 pmRNSPrice Monitoring Extension
16th Mar 20239:05 amRNSSecond Price Monitoring Extn
16th Mar 20239:00 amRNSPrice Monitoring Extension
8th Mar 20237:00 amRNSDisposal of Russian Assets
14th Feb 20234:41 pmRNSSecond Price Monitoring Extn
14th Feb 20234:35 pmRNSPrice Monitoring Extension
14th Feb 20232:05 pmRNSSecond Price Monitoring Extn
14th Feb 20232:00 pmRNSPrice Monitoring Extension
13th Feb 20239:00 amRNSPrice Monitoring Extension
13th Jan 202311:05 amRNSSecond Price Monitoring Extn
13th Jan 202311:00 amRNSPrice Monitoring Extension
28th Oct 20227:00 amRNSResult of AGM
6th Oct 20222:30 pmRNSNotice of AGM
30th Sep 20227:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.